We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vycor Medical Inc (QB) | USOTC:VYCO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0899 | 0.061 | 0.0899 | 0.00 | 13:30:25 |
CUSIP No.
92921M203
|
13D
|
|
1.
|
NAMES OF REPORTING
PERSONS
Fountainhead
Capital Management Limited
|
2.
|
CHECK THE
APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
☐
|
3.
|
SEC USE
ONLY
|
4.
|
SOURCE OF
FUNDS
OO (See Item 3
below)
|
5.
|
CHECK BOX IF
DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d)
or 2(e)
☐
|
6.
|
CITIZENSHIP OR
PLACE OF ORGANIZATION
Jersey, Channel
Islands
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
6,586,053
|
8.
|
SHARED VOTING POWER
0
|
|
9.
|
SOLE DISPOSITIVE
POWER 6,586,053
|
|
10.
|
SHARED DISPOSITIVE
POWER 0
|
11.
|
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,586,053
|
12.
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
|
13.
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
49.36%
|
14.
|
TYPE OF REPORTING
PERSON
CO
|
(a)
|
The Reporting
Person is the beneficial owner of 6,586,053 shares of the
Company’s common stock, representing 49.36% of the
outstanding shares of the Company’s common stock. Said amount
includes all shares issuable to the Reporting Person on account of
all Warrants held by the Reporting Person convertible or
exercisable within sixty (60) days of the date of this report.
Other than as described therein, the Reporting Person does not own
any other securities of the Company. The holder believes the number
of shares of the Company’s outstanding common stock to
be 11,116,077 as of September 29, 2016.
|
(b)
|
The Reporting
Person has the sole power to vote and dispose of the 6,586,053
shares, less the number of shares which are currently subject to
issuance only upon the exercise of Warrants.
|
(c)
|
Except for the
transactions described in the Explanatory Note above, the Reporting
Person did not effect any transactions in the issuer’s
securities within the past 60 days.
|
(d)
|
No other person is
known to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale of, the
Reporting Person’s securities.
|
(e)
|
Not
applicable.
|
Dated:
October 11, 2016
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Mark Andrews
|
|
Name: Mark
Andrews for and on behalf of Berwin Limited,
Director
|
|
|
|
|
|
|
|
|
By:
|
/s/ Eileen O’Shea
|
|
Name: Eileen
O’Shea, for and on behalf of Moulton imited,
Director
|
|
1 Year Vycor Medical (QB) Chart |
1 Month Vycor Medical (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions